Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stevenson

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Nature Medicine|April 8, 2015
Corrigendum: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, et al.
The Journal of Pediatrics|January 14, 2012
Gastrointestinal bleeding in infantile hemangioma: a complication of segmental, rather than multifocal, infantile hemangiomasBeth A Drolet, Elena Pope, Anna M Juern, et al.
American Journal of Medical Genetics. Part A|January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiersJoseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Journal of Pediatric Orthopedics|August 28, 2020
Are Some Randomized Clinical Trials Impossible?Jonathan J Rios, B Stephens Richards, David A Stevenson, et al.
European Journal of Human Genetics : EJHG|June 13, 2018
Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformationWhitney L Wooderchak-Donahue, Peter Johnson, Jamie McDonald, et al.
Pediatric Transplantation|July 2, 2019
Cardiac transplantation in children with Noonan syndromeLeslie M McCallen, Rebecca K Ameduri, Susan W Denfield, et al.
Neurology|July 7, 2021
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2Srivandana Akshintala, Nashwa Khalil, Kaleb Yohay, et al.
Clinical Trials (London, England)|September 29, 2023
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1Andrea M Gross, Scott R Plotkin, Nelson B Watts, et al.
HGG Advances|February 4, 2021
Missense substitutions at a conserved 14-3-3 binding site in HDAC4 cause a novel intellectual disability syndromeEmma Wakeling, Meriel McEntagart, Michael Bruccoleri, et al.
American Journal of Medical Genetics. Part A|December 23, 2011
Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delayEric A Muller, Swaroop Aradhya, Joan F Atkin, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Nature Medicine|April 8, 2015
Corrigendum: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, et al.
The Journal of Pediatrics|January 14, 2012
Gastrointestinal bleeding in infantile hemangioma: a complication of segmental, rather than multifocal, infantile hemangiomasBeth A Drolet, Elena Pope, Anna M Juern, et al.
American Journal of Medical Genetics. Part A|January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiersJoseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Journal of Pediatric Orthopedics|August 28, 2020
Are Some Randomized Clinical Trials Impossible?Jonathan J Rios, B Stephens Richards, David A Stevenson, et al.
European Journal of Human Genetics : EJHG|June 13, 2018
Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformationWhitney L Wooderchak-Donahue, Peter Johnson, Jamie McDonald, et al.
Pediatric Transplantation|July 2, 2019
Cardiac transplantation in children with Noonan syndromeLeslie M McCallen, Rebecca K Ameduri, Susan W Denfield, et al.
Neurology|July 7, 2021
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2Srivandana Akshintala, Nashwa Khalil, Kaleb Yohay, et al.
Clinical Trials (London, England)|September 29, 2023
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1Andrea M Gross, Scott R Plotkin, Nelson B Watts, et al.
HGG Advances|February 4, 2021
Missense substitutions at a conserved 14-3-3 binding site in HDAC4 cause a novel intellectual disability syndromeEmma Wakeling, Meriel McEntagart, Michael Bruccoleri, et al.
American Journal of Medical Genetics. Part A|December 23, 2011
Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delayEric A Muller, Swaroop Aradhya, Joan F Atkin, et al.
Pageof 17